An audit of 12 cases of long COVID following the lightning process intervention examining benefits and harms, 2025, Arroll et al

Nina E. Steinkopf has today published a letter to the editor regarding the lightning process and this study

Letter to editor regarding the lightning process

quote:

In the article “An audit of 12 cases of long COVID following the lightning process intervention examining benefits and harms” the authors «aimed to conduct an independent, university-based audit on the first long COVID patients treated by the only full-time LP practitioner in New Zealand,…”.

The method is described as “a retrospective, cross-sectional audit.” Readers are informed that “Ethics approval is not required in New Zealand for audits of clinical practice.”

This gives the impression that the article is a report from an audit of a clinical practice and that ethics approval was not required.

It is important to clarify that this is not the case.

 
Journal of Family Medicine and Primary Care 14(2):p 796-799, February 2025. | DOI: 10.4103/jfmpc.jfmpc_1049_24

This link on page 1 naturally goes to the current issue of this Journal. But as the date is given on this link, I can still find the paper in the Feb 2025 issue of this very interesting Journal - all open access - hundreds of topical pages in each issue.

All the authors I scanned though two lengthy journal issues have names sounding Indian or Arabian, except for Arroll's paper and one next to his in the 2025 issue

Looks like one aim was to spread an LP advert through India and Saudi Arabia

Updated link to Arroll's paper purporting to:

- audit 12 cases of Long Covid following the LP intervention, pros and cons

--------------------------------------------------------
 
Last edited:
February the 24th 2025

Ethics approval is not required in New Zealand for audits of clinical practice

Huh. Because this reads to me more as an observational case series than an audit of clinical practice.
Good shout. Would it be possible to report them? Are we certain of this assessment?
Promotional case series would be more accurate ... reporting positive benefits is literally what the LP is ... absurd ... bias ... misrepresentation .. fraudulent in almost every other context ... people .. actually face investigations for fraud.
problem with this "audit" is that self-reports of improvement due to LP can't be taken at face value, because LP teaches participants to misreport.

Self-reports would have to be checked against objective outcomes, and this "audit" doesn't include any.
... how many dropped out of the "treatment"?

1st published correction took 6 months. Gave no reason. October 2025:

Erratum

the statement under section Methods in 2nd paragraph is incorrectly written as

“Ethics approval is not required in New Zealand for audits of clinical practice.”

The correct statement should be read as

“The study was deemed out of scope for HDEC approval.” Link
By whom? The researchers or HDEC?
I expect it was the researchers.

I should make a complaint about this - it wasn't an audit of clinical practice, and, even if it was, there was enough risk and consequence to make it qualify for an ethics review.

December the 30th 2025:

Nina E. Steinkopf quote:

the authors "aimed to conduct an independent, university-based audit ... The method is described as “a retrospective, cross-sectional audit .... Ethics approval is not required in New Zealand for audits of clinical practice.”

This gives the impression that the article is a report from an audit of a clinical practice and that ethics approval was not required. It is important to clarify that this is not the case.
 
January the 28th 2026:

Then the good NZ Doctor - upon reviewing the anomaly - managed to publish the Arroll reply to criticism at 12:14, with the critcism following at 12:15. It goes like this

Appleby says there is no quality evidence. In so many words Arroll replies: there is strong evidence but you overlooked it you silly woman. Yah boo.

He also maintains that his critics disike the LP. How perceptive is that? His critics dislike LP so they catastrophise an imaginary harm.

He must insist that strong evidence of its benefits - albeit anecdotal - must outweigh the evidence of harm because ... harm is anecdotal.

Oh and its because he is "congruent with the Oslo Consortium" which must have impressed New Zealand no end.

He does not do adult conversation. Its a dodgy way to lose this vast trust placed in him by GPs who need a guiding light in family medicine. He did get so accustomed to his word upheld as gospel, he forgot.

He cannot bring himself to specify the alleged harms. He makes such a fuss but half the LC patients were "not diagnosed". He embarrassed the "University of Auckland Research Fund for Professor Bruce Arroll", VIP

Says NZ Doctor: "In the complex world of chronic fatigue-related syndromes, there is an equally complex and long-term controversy going on.

12:14

""Specialist GP Bruce Arroll responds to criticisms of an audit on the use of the Lightning Process for long COVID: 'The so-called harms of the Lightning Process are anecdotal and are confused with not liking the L...'

12:15

""Nurse practitioner Catherine Appleby says clinicians need impartial information about the Lightning Process and its associated risks: 'In February 2025, the article “Using Lightning Process to break cycle of fatigue in long COVID” was ...'
 
Last edited:
Was this type of explicit indoctrination actually proposed or implemented in one of the Nordic countries, by means of confiscating essential income top-ups if not compliant?

That was horrific. WIll the state revert to trial by church courts for not attending church? Trial by ordeal? Or was it a proponent with a different doctrine being imposed, up north. I forget.

If it was this unpopular program proposed up north, then is that the ultimate goal of this author's propositioning - to obtain clients only by impoverishing them? Is the state that keen to pay the price, as a "saving"?

What else is on offer at such a cost, as compared by Arroll the competing contender, ready to pounce on any critic (so smart, calling them dimwits).

Does he by any chance lecture to insurance companies? What commerce is citing his LP advert? Where are the citations listed? I can't find these citations in this lovely Journal of Family Medicine & Primary Care.

GPs could be suspicious. Oddly assured by anecdote its emphatically safe, curative and cost-effective, ready to roll, kindly refer your patient now, all pros, no cons reported. So why beg for randomised trials?
 
Last edited:
All the authors I scanned though two lengthy journal issues have names sounding Indian or Arabian, except for Arroll's paper and one next to his in the 2025 issue

Looks like one aim was to spread an LP advert through India and Saudi Arabia
Hardly surprising to have that author list given that the journal is based in India and says:
"The journal promotes the primary care research activities of the WONCA (World Organization of Family Doctors) South Asia Region members."
https://journals.lww.com/jfmpc/pages/affiliatedsociety.aspx
I guess it was the only journal willing to take this article.
 
I guess it was the only journal willing to take this article.

Then he ran out of GPs to impress at home. South & South East Asia regions may be closely linked to Australasia / New Zealand. Can he see the rituals of a Lightning Process catching hold in Asia? Or is he just gaming the citations?

One need look no further. His boomerang references cite an Oslo Consortium with known associates ready to cite his expert anecdotes as evidence: a highly organised "independent" report on the few remaining patients (still standing)

Snowballing citations melted in a hasty hothouse, all citing patient anecdotes cherry-picked to exclude anecdotal harm. Racing time along the leylines, to run right into three new Guideline evaluations: Nordic-Middle Europe-Aussie

Arroll will then complain again: LP & GET was objective just disrespected.

As Arroll said: "here is a need to develop evidence-based treatment options"

Because highly trained and educated, professional re-programming provision collected LP and GET data for 20 yrs but its not presentable, it cannot prove objective efficacy to any standard, it can but growl out:

LP & GET is objective just disrespected.

"the data reported ... from telephone interviews using a questionnaire specifically developed for this study...

"Participants were eligible if they had undergone the LP for long COVID symptoms after an acute COVID infection

"irrespective of whether a confirmatory health professional diagnosis had been sought...

"To ascertain possible harms, we asked: “Did you experience any harm while doing the LP?". Lol. That proves it.

What harm? He talks so much about unspecified "harms"

"Primary care clinicians can be assured that this is likely to be a safe and effective intervention. Randomized trials are indicated."

LP & GET are plain disrespected. We will take your rejects dit-dit-dit.
 
Does he by any chance lecture to insurance companies? What commerce is citing his LP advert? Where are the citations listed? I can't find these citations in this lovely Journal of Family Medicine & Primary Care.
I don't know what links Bruce Arrow has to insurance companies. I note that in 2021 he received the Supreme Award in the NZ Primary Healthcare Awards. The sponsor of the Supreme Award is the Accident Compensation Corporation, the government organisation that effectively acts as the nation's health insurer, collecting levies from employers to then take care of people injured or harmed in accidents. Workers who have developed Long Covid after infections probably contracted at work have found it difficult to get support through the ACC.
ACC Supreme Award 2021
Judges wowed by long-serving professor’s qualities of ingenuity, humility, generosity

A 41-year career pursuing excellence and generously sharing his knowledge and good humour brought academic GP Bruce Arroll the top award in the 2021 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora.

Bruce Arroll, GP and general practice founder, academic, family man, innovator, proponent of Te Tiriti o Waitangi principles and award winner, has plenty more gas in the tank, he tells reporter Martin Johnston
There are other articles all noting Bruce Arroll won the award e.g.
"Empathy the x-factor as GP Bruce Arroll tops the Primary Healthcare Awards"

I found that Arroll was a co-author on a number of studies commissioned by the Accident Compensation Corporation that seem to encourage GPs to do less testing for things like low back pain, and instead to encourage patients to have positive expectations and have self-efficacy.
link here to a site of one of his co-authors
Work for Accident Compensation Corporation (ACC)
Between 1999 and 2007 I was commissioned by the New Zealand Accident Compensation Commission (ACC) to conduct number of research projects. My colleague Bruce Arroll was also assisted in this research and is co-author on a number of the publications. Some of the later work involved other co-authors. Reports were produced for ACC for each commissioned work and the findings were also published in peer-reviewed journals.


Imaging and referrals with respect to acute and chronic low back pain
In 2001 I conducted a literature review and research to provide recommendations to ACC regarding imaging and referrals with respect to acute and chronic low back pain:

Recommendations for GPs regarding imaging with respect to low back pain: a Delphi and evidence-based study
Goodyear-Smith F, Arroll B New Zealand Family Physician, 29 (2): 97-101, 2002
Abstract
Introduction: Despite evidence-based guidelines, plain x-rays are used more extensively than recommended in low back pain, do not help diagnose simple back pain or nerve root problems and carry high false-positive risk.

Aim: To review the literature regarding GPs’ use of plain x-ray and determine expert opinion regarding use of these investigations.
Method: A literature review and modified two-round Delphi consultation was conducted with a panel of GPs and other relevant practitioners.

Results: There was consensus that most low back pain resolves, and spondylosis and disc degeneration findings are common in both symptomatic and non-symptomatic patients, hence in absence of trauma or other ‘red flags’ lumbar spine x-rays should be avoided for 4-6 weeks. X-rays are recommended where serious pathology is suspected. Opinion was mixed regarding MRI as first-line investigation. Lumbar x-rays require 30-40 times the dose of chest x-ray radiation.

Conclusion: Where there is consensus on the literature GPs should adhere to recommendations. Lack of consensus justifies GP clinical flexibility. A greater awareness by doctors and patients of radiation levels involved may diminish ordering lumbar x-rays when serious pathology is unlikely.


GP management and referral of low back pain: a Delphi and evidence-based study
Goodyear-Smith F, Arroll B. New Zealand Family Physician, 29 (2): 102-107, 2002
Abstract
Background: Numerous evidence-based guidelines on low back pain management have been produced but specific conditions for General Practitioner (GP) referral are not always specified.

Aim: Literature review and expert consultation to determine best management circumstances and timing of referral to other health practitioners.
Method: Multi-disciplinary panel underwent two-round Delphi consultation assessing their opinions and degree of agreement to evidence-based statements.

Results: Conservative treatment should include information about low back pain; reinforcement of positive expectations; education about self-management and self-responsibility, pain management and control and increase in exercise tolerance. NSAIDs, muscle relaxants and manipulation should be considered if there is no radicular pain. Referral for steroid epidural injections, TENS, acupuncture, traction and lumbar support should be avoided. Clinically severe nerve impingement requires referral to orthopedic surgeons. There was consensus that referral should occur if no improvement after 6 weeks and certainly after 12 weeks. To whom GPs should refer is not clear.

Conclusion: Where there is good evidence there is usually a consensus regarding management and referral for back pain, for example no or limited referral for acute pain. Where there is no or equivocal evidence then clinical judgement for individuals is needed. More randomised controlled trials are required to elucidate the best persons to whom GPs should refer patients with subacute or chronic back pain.
 
Last edited:
Back
Top Bottom